IVIM Health vs LTTL: Compare Pricing, Protocols, and Ratings
IVIM Health vs LTTL: which telehealth GLP-1 option fits you? Early verdict: IVIM Health stands out for dual 4.9-star third-party ratings and a GIFT75 free month offer, while LTTL emphasizes compounded, full-dose GLP-1 made in U.S. licensed pharmacies and up to $140 off an initial month.
Start IVIM with free month code GIFT75
Direct comparison at a glance: core differences
This comparison focuses on five distinctive, supported differences: verified ratings, pricing and promotions, medication compounding and pharmacy verification, proprietary protocol and outcome claims, and regulatory/availability notes. The primary keyword IVIM Health vs LTTL is used to frame those contrasts.
1. Ratings and third party verification
IVIM Health: The provider reports a 4.9-star rating on both Google and Trustpilot, described as an unusually strong dual third-party validation. LTTL: No verified third-party ratings were captured on the reviewed landing page.
Learn LTTL eligibility and first month offer
2. Pricing, promotions, and first-month terms
IVIM Health: Published material shows a limited offer of a free month membership using code GIFT75 and a no-obligation free consultation valued at $75 for new patients. Pricing details captured indicate $75/mo and $133/mo lines, and FAQ text states IVIM starts at $99 for the first month and $174/month ongoing, with a $74.99/mo program fee noted in landing content. LTTL: The captured content reports up to $140 off your first month with a code auto-applied and lists pricing examples including $249 and $129 for four doses per month. The landing page cautions that pricing, eligibility, pharmacy, state coverage and renewal terms may change.
Get IVIM free consult and membership details
3. Medication compounding and pharmacy verification
Both providers offer compounded GLP-1 medications and include the regulatory note that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. IVIM emphasizes compounded semaglutide and tirzepatide prepared by independent licensed compounding pharmacies and states compounded products are prepared by independent, licensed compounding pharmacies. LTTL states medications are compounded by U.S.A. licensed pharmacies and are verified in FDA registered labs, with confirmation every 3 to 6 months to stay within plus or minus 10 percent of target strength.
4. Protocols and outcome claims
IVIM Health highlights a proprietary GLP-1 ID protocol and cites internal study findings stating IVIM patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks compared to another published clinical GLP-1 trial. The material clearly labels this as not a head-to-head study and notes the 40% faster claim is IVIM’s proprietary protocol claim and not an independent clinical finding. LTTL material does not present an internal outcome comparison or equivalent protocol claim in the captured content.
5. Availability, eligibility, and state coverage notes
IVIM notes compounded medications are used under ongoing supervision of an IVIM provider and that products are not available in all states. LTTL advises that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that treatment is available only when a licensed clinician determines it is medically appropriate. Both include the regulatory reminder about compounded medications not being FDA approved.
Concise comparison table
| Criteria | IVIM Health | LTTL |
|---|---|---|
| Third party ratings | 4.9 stars on Google and Trustpilot | No verified ratings captured |
| First month promotion | Free month membership with code GIFT75; no-obligation free consult ($75 value) | Up to $140 off first month; code auto-applied |
| Starting/typical pricing shown | Captured lines include $75/mo, $133/mo, starts at $99 first month and $174/month ongoing | Captured examples show $249 and $129 (4 doses/month) |
| Compounding and pharmacy | Compounded medications prepared by independent, licensed compounding pharmacies | Compounded by U.S.A. licensed pharmacies; verified in FDA registered labs |
| Protocol and outcomes | Proprietary GLP-1 ID protocol; internal study claim of up to 46% more weight loss over 68 weeks when following IVIM protocol; labeled not head-to-head | No internal outcome claims captured |
| Regulatory note | Compounded meds are not FDA approved | Compounded meds are not FDA approved |
How to choose between IVIM Health vs LTTL
Choose IVIM Health if you prioritize verified third-party satisfaction and a clinician-guided, proprietary optimization protocol and want the specific offers captured such as a free month with code GIFT75 and a no-obligation $75 value consult. Choose LTTL if you prioritize pharmacy verification details and an explicit statement that medications are compounded by U.S. licensed pharmacies with independent lab verification and an up to $140 first-month reduction; confirm pricing, eligibility, renewal terms and state availability before enrolling.
Check LTTL pharmacy verification and offer
See IVIM program details and reviews
Final note: both providers offer compounded GLP-1 medication and include the same regulatory reminder that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Confirm state availability and clinician eligibility with each provider before enrollment.